FI72146C - Procedure for Identifying Nucleic Acids. - Google Patents
Procedure for Identifying Nucleic Acids. Download PDFInfo
- Publication number
- FI72146C FI72146C FI850004A FI850004A FI72146C FI 72146 C FI72146 C FI 72146C FI 850004 A FI850004 A FI 850004A FI 850004 A FI850004 A FI 850004A FI 72146 C FI72146 C FI 72146C
- Authority
- FI
- Finland
- Prior art keywords
- hybridization
- poly
- probe
- affinity pair
- dna
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 28
- 150000007523 nucleic acids Chemical class 0.000 title claims description 17
- 108020004707 nucleic acids Proteins 0.000 title claims description 15
- 102000039446 nucleic acids Human genes 0.000 title claims description 15
- 239000000523 sample Substances 0.000 claims description 57
- 238000009396 hybridization Methods 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 239000000700 radioactive tracer Substances 0.000 claims description 2
- 229910000083 tin tetrahydride Inorganic materials 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- 239000013612 plasmid Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
- 241000701161 unidentified adenovirus Species 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229910052747 lanthanoid Inorganic materials 0.000 description 2
- 150000002602 lanthanoids Chemical class 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- BRLRJZRHRJEWJY-VCOUNFBDSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[3-[3-(4-azido-2-nitroanilino)propyl-methylamino]propyl]pentanamide Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCN(C)CCCNC1=CC=C(N=[N+]=[N-])C=C1[N+]([O-])=O BRLRJZRHRJEWJY-VCOUNFBDSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 241000283160 Inia Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- JGQHTPYIIXRFLR-UHFFFAOYSA-N [2-(9h-fluoren-1-yl)-2-oxoethyl] acetate Chemical class C1C2=CC=CC=C2C2=C1C(C(=O)COC(=O)C)=CC=C2 JGQHTPYIIXRFLR-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Description
721 46721 46
Menetelmä nukleiinihappojen tunnistamiseksiMethod for identification of nucleic acids
Keksinnön kohteena on menetelmä nukleiinihappojen tunnistamiseksi liuoksessa tapahtuvan hybridisaaticn avulla.The invention relates to a method for the identification of nucleic acids by hybridization in solution.
05 Keksinnön mukaiselle menetelmälle on tunnusomaista, että hybridisaatioreaktiossa käytetään kahta samassa liuoksessa olevaa koetinta. Detektorikoetin on leimattu merkkiaineella ja nk. kiinnitinkoettimeen on kiinnitetty komponentti, joka voi toimia osapuolena affiniteetiparissa, jolloin hybridi-10 säätiössä muodostunut kiinnitinkoetin:näyte:detektorikoetin--hybridi voidaan erottaa muista hybridisaatioseoksessa olevista komponenteista affiniteettiparin toisen osapuolen avulla.The method according to the invention is characterized in that two probes in the same solution are used in the hybridization reaction. The detector probe is labeled with a marker and a so-called clamp the probe is attached to a component that can act as a party affiniteetiparissa, the hybrid-formed foundation fastener 10 probe: the sample. Detector probe - the hybrid may be separated from other components of the hybridization mixture for the second party by means of an affinity pair.
15 Nukleiinihappojen tunnistamisessa on käytetty erilaisia hybridisaatiomenetelmiä. Esimerkkeinä voidaan mainita suorat hybridisaatiomenetelmät ja kerroshybridisaatiomenetelmät. Suorissa hybridisaatiomenetelmissä nukleiinihapponäyte on joko liuoksessa tai kiinnitettynä kiinteään kantajaan.Various hybridization methods have been used to identify nucleic acids. Examples include direct hybridization methods and layer hybridization methods. In direct hybridization methods, the nucleic acid sample is either in solution or attached to a solid support.
20 Tunnistettava nukleiinihappo osoitetaan käyttäen yhtä leimattua koetinta. Kerroshybridisaatiomenetelmissä (ΓΙ 63596) käytetään kahta erillistä koetinta, joilla osoitetaan tunnistettava nukleiinihappo näyteliuoksesta. Toinen käytetyistä koettimista on leimattu merkkiaineella ja toinen on 25 kiinnitetty kiinteään kantajaan.The nucleic acid to be identified is detected using a single labeled probe. Layer hybridization methods (ΓΙ 63596) use two separate probes to detect the identifiable nucleic acid from the sample solution. One of the probes used is labeled with a marker and the other is attached to a solid support.
Olemme kehittäneet uuden hybridisaatiomenetelmän, jossa käytetään kahta erilaista koetinta mutta molemmat koettimet ovat samassa liuosfaasissa. Koska hybridisaatioon osallistuva 30 näyte ja molemmat koettimet ovat samassa liuosfaasissa, hybridisaatioreaktio tapahtuu huomattavasti nopeammin kuin kerroshybridisaatiossa, jossa toinen koetin on kiinnitetty kiinteään kantajaan. Keksinnön mukaisessa menetelmässä tunnin inkubointiaika on riittävä. Yksivaiheisessa kerroshybridi-35 säätiössä (FI 63596) riittävä hybridisaatio tapahtuu vasta 12 2 721 46 tunnissa. Kun suoritetaan kaksivaiheista kerroshybridisaati-ota, tarvitaan vähintään 24 tunnin hybridisaatioaika (Dunn ja Hassell, Cell 12, 23-36, 1977).We have developed a new hybridization method using two different probes but both probes are in the same solution phase. Because the sample involved in the hybridization and both probes are in the same solution phase, the hybridization reaction proceeds significantly faster than in layer hybridization, where one probe is attached to a solid support. In the method according to the invention, an incubation time of one hour is sufficient. In a single-stage layered hybrid-35 foundation (FI 63596), sufficient hybridization occurs only in 12 2 721 46 hours. When performing a two-step layer hybridization, a hybridization time of at least 24 hours is required (Dunn and Hassell, Cell 12, 23-36, 1977).
05 Keksinnön mukaisessa menetelmässä käytetään edullisesti kahta koetinta. Koettimet ovat tunnistettavaksi tarkoitetulle nukleiinihapolle riittävän homologisia nukleiinihappofrag-mentteja. On edullista, mutta ei välttämätöntä, jos koettimet ovat homologisia suhteellisen lähellä toisiaan sijaitseville 10 kohdille tunnistettavassa nukleiinihapossa. Koettimet eivät saa olla toisilleen homologisia.In the method according to the invention, two probes are preferably used. The probes are nucleic acid fragments sufficiently homologous to the nucleic acid to be identified. It is preferred, but not essential, that the probes be homologous to relatively close to 10 sites in the nucleic acid to be identified. The probes must not be homologous to each other.
Koettimet voidaan valmistaa synteettisesti, puolisynteetti-sesti, yhdistelmä-DNA-tekniikalla tai suoraan luonnosta 15 eristetyistä nukleiinihapoista. Koetin voi olla sopivaan vektoriin sidottu. Se voi sisältää vektoriosia tai olla täysin vapaa vektoriosista.Probes can be prepared synthetically, semi-synthetically, by recombinant DNA technology, or directly from nucleic acids isolated from nature. The probe may be bound to a suitable vector. It may contain vector elements or be completely free of vector elements.
Detektorikoetin on leimattu sopivilla merkkiaineilla.The detector probe is labeled with suitable markers.
20 Merkkiaineina voidaan käyttää erilaisia radioaktiivisia isotooppeja tai radioaktiivisesti leimattuja yhdisteitä. Merkkiaine voi myös olla fluoresoiva, luminesoiva, valoa emittoiva, entsymaattisesti tai immunologisesti osoitettavissa oleva jne. Esimerkkeinä voidaan mainita biotiinin ja 25 avidiinin tai streptavidiinin affiniteettiin perustuvat merkkiaineet (Leary et ai., P.N.A.S. 80, 4045-4049, 1983), lantanidikelaatit (US 4,243,880 ja US 4,374,120), ferritiini-ja hemeyhdisteet, immunologisesti osoitettavat hapteenit kuten AAF ja AIF (erilaiset asetoksiasetyylifluoreenideri-30 vaatit (WO 8302286)). Myös proteiinien välityksellä tapahtuva tunnistaminen on mahdollista. Keksinnön mukainen menetelmä ei ole riippuvainen käytetystä merkkiaineesta. Menetelmään voidaan vapaasti soveltaa kaikki tunnetut nukleiinihappo-hybridisaatioon soveltuvat merkkiaineet.Various radioactive isotopes or radiolabeled compounds can be used as tracers. The label may also be fluorescent, luminescent, light emitting, enzymatically or immunologically detectable, etc. Examples include labels based on the affinity of biotin and avidin or streptavidin (Leary et al., PNAS 80, 4045-4049, 1983), lanthanide chelates (US lanthanide chelates). and U.S. 4,374,120), ferritin and hemic compounds, immunologically detectable haptens such as AAF and AIF (various acetoxyacetylfluorene derivative requirements (WO 8302286)). Protein-mediated identification is also possible. The method according to the invention is not dependent on the tracer used. All known markers suitable for nucleic acid hybridization are freely applicable to the method.
Il 72146 3Il 72146 3
Kiinnitinkoettimeen on kiinnitetty komponentti, joka voi toimia osapuolena affiniteettiparissa. Tällaisia affiniteet-tipareja ovat esimerkiksi biotiini-avidiini tai biotiini-streptavidiini, raskasmetalliderivaatti-tioryhmä (Dale and 05 Ward, Biochemistry 14, No 11, 2458-2469, 1975), erilaiset homopolynukleotidit, esimerkiksi poly dG - poly dc, poly dA - poly dT tai poly dA - poly U. Mutta myös muita affiniteettipareja voidaan käyttää, kunhan komponenteilla on tarpeeksi voimakas affiniteetti toisiinsa. Immunologisissa 10 menetelmissä käytettyjen ligandien ja konjugaattien joukosta löytyy sopivia affiniteettipareja.Attached to the fastener probe is a component that can act as a party in the affinity pair. Such affinity droplets are, for example, biotin-avidin or biotin-streptavidin, a heavy metal derivative thio group (Dale and 05 Ward, Biochemistry 14, No. 11, 2458-2469, 1975), various homopolynucleotides, for example poly dG - poly dc, poly dA - poly dT or poly dA - poly U. But other affinity pairs can also be used as long as the components have a sufficiently strong affinity for each other. Among the ligands and conjugates used in immunological methods, suitable affinity pairs can be found.
Ennen hybridisaatioreaktion suorittamista näyte käsitellään siten, että nukleiinihapot vapautuvat hybridisaatioliuokseen 15 yksisäikeisessä muodossa. Hybridisaatio suoritetaan hybridi-saatioseoksessa, jossa nukleiinihapot, detektorikoetin ja kiinnitinkoetin on tarvittaessa saatettu yksisäikeiseen muotoon. Hybridisaatioliuoksena voidaan käyttää erilaisia tarkoitukseen sopivia puskureita. Hybridisaatio tapahtuu 20 lämpötilavälillä 0-80°C, mutta edullista on käyttää 65°C:n lämpötilaa. Jos hybridisaatioliuos sisältää formamidia (40-55 %), voidaan käyttää 37°C lämpötilaa. Hybridisaatio-ajaksi riittää tunti.Prior to performing the hybridization reaction, the sample is treated so that the nucleic acids are released into the hybridization solution in a single-stranded form. The hybridization is performed in a hybridization mixture in which the nucleic acids, the detector probe and the attachment probe have been brought into a single-stranded form, if necessary. Various suitable buffers can be used as the hybridization solution. Hybridization occurs at a temperature in the range of 0-80 ° C, but it is preferred to use a temperature of 65 ° C. If the hybridization solution contains formamide (40-55%), a temperature of 37 ° C can be used. An hour is enough for the hybridization time.
25 Kun hybridisaatio on tapahtunut, liuosta laimennetaan tarvittaessa siten, että olosuhteet ovat edullisia affini-teettiparille. Tämän jälkeen seos saatetaan kontaktiin affiniteettiparin toisen osapuolen kanssa, joka on kytkettynä sopivaan kantajaan. Kantajana voi toimia esimerkiksi affini-30 teettikromatografiapylväs, filtteri, muovi- tai lasipinta.Once hybridization has taken place, the solution is diluted, if necessary, so that the conditions are favorable for the affinity pair. The mixture is then brought into contact with the other party of an affinity pair which is coupled to a suitable carrier. The support can be, for example, an affinity chromatography column, a filter, a plastic or glass surface.
Affiniteettikantajan materiaali voi olla esimerkiksi selluloosaa, latexia, polyakrylamidia, dextraania tai agaroosia. Näitä materiaaleja voidaan käyttää myös suspensioina 35 koeputkessa. Edullista on myös käyttää koeputkia, joiden 4 72146 sisäpintaan on kiinnitettynä affiniteettiparin toinen osapuoli. Materiaalien valinta edellyttää, että siihen voidaan kiinnittää komponentti, jolla on affiniteettia kiinnitinkoettimeen kiinnitettyyn komponenttiin.The material of the affinity carrier may be, for example, cellulose, latex, polyacrylamide, dextran or agarose. These materials can also be used as suspensions in 35 test tubes. It is also preferred to use test tubes with the other side of the affinity pair attached to the inner surface of the 4 72146. The choice of materials requires that a component with affinity for the component attached to the attachment probe be attached.
0505
Mikäli näyte sisältää tunnistettavaksi tarkoitettua nukleiinihappoa, hybridisaatiossa syntyy kiinnitinkoetin:näyte: detektorikoetin-hybridi. Tämä hybridi tarttuu fraktioinnissa kiinteään kantajaan. Kantajaan tarttuneen fraktion leima 10 voidaan mitata tavanomaisin menetelmin suoraan kantajasta tai eluoinnin jälkeen eluoidusta liuoksesta.If the sample contains nucleic acid for identification, hybridization results in an attachment probe: sample: detector probe hybrid. This hybrid adheres to the solid support during fractionation. The label 10 of the fraction adhering to the support can be measured by conventional methods directly from the support or from the solution eluted after elution.
Fraktioinnissa voidaan affiniteettikromatografiän tilalla käyttää myös muita järjestelmiä, esimerkiksi faasiekstrakti-15 ota tai magneettikenttiä.Other systems, such as phase extract or magnetic fields, can be used in the fractionation instead of affinity chromatography.
Seuraavissa sovellutusesimerkeissä keksinnön mukainen menetelmä kuvataan tarkemmin. Keksinnön mukainen menetelmä ei ole riippuvainen esimerkeissä käytetyistä nukleiinihappo-20 fragmenteista. Alan asiantuntijalle on itsestään selvää miten vastaavanlaisia nukleiinihappofragmentteja voidaan valmistaa.In the following application examples, the method according to the invention is described in more detail. The method of the invention is not dependent on the nucleic acid-20 fragments used in the examples. It will be apparent to one skilled in the art how similar nucleic acid fragments can be prepared.
Esimerkki 1 25 Adenoviruksen DNA:n tunnistaminen solulysaatista käyttäen homopolynukleotidia 125Example 1 Identification of adenovirus DNA from a cell lysate using homopolynucleotide 125
Detektorikoettimena käytettiin lilla leimattua rekombi-nanttifaagia mkTH 1206, joka on adenoviruksen (tyyppi 2) 30 Bgl II fragmentti adenoviruksen geenikartan positiosta 42-45,3 %. Kyseinen rekombinanttifaagi on deponoitu kantakokoelmaan Deutsche Sammlung von Mikroorganismen numerolla DSM 2827 ja sen spesifinen aktiivisuus on 7 7 x 10 cpm/jug DNA. Koetin on kuvattu tarkemmin julkaisussa 35 Ranki et ai., Gene 21., 77-85, 1983.Purple-labeled recombinant phage mkTH 1206, a 30 Bgl II fragment of adenovirus (type 2) from position 42-45.3% of the adenovirus gene map, was used as a detector probe. This recombinant phage has been deposited in the strain collection Deutsche Sammlung von Mikroorganismen under number DSM 2827 and has a specific activity of 7 7 x 10 cpm / μg DNA. The probe is described in more detail in 35 Ranki et al., Gene 21., 77-85, 1983.
5 721465 72146
Kiinnitinkoettimena käytettiin rekombinanttiplasmidia pkTH 1202, joka on deponoitu kantakokoelmaan Deutsche Sammlung von Mikro-organismen numerolla DSM 2824 ja koostuu adenoviruksen BamHI D fragmentista (karttapositio 29-42 %) kloonattuna 05 pBR322 plasmidiin. Rekombinanttiplasmidi pkTH 1202 (DSM 2824) pilkottiin restriktioentsyymillä Hae III ja fragmenttien 3' päihin liitettiin poly A-häntä terminaalitransferaasient-syymin avulla. Hännän pituus mitattiin H-A inkorporaatiolla. Pituus oli keskimäärin n. 70 A-tähdettä. Ennen käyttöä 10 kiinnitin denaturoitiin keittämällä. Näytteenä käytettiin adenovirukselle infektoituja A-549 soluja. Infektoituja soluja inkuboitiin 2i tuntia. Solut kerättiin ja rikottiin 1 %:lla natriumdodekyylisulfaattiliuoksella. Liuos sisälsi n. 106 solua/ml. Viskositeetti alennettiin sonikoimalla.The recombinant plasmid pkTH 1202, deposited in the strain collection Deutsche Sammlung von Microorganism under the number DSM 2824 and consisting of a BamHI D fragment of adenovirus (map position 29-42%) cloned into plasmid pBR322, 05 was used as a ligand probe. The recombinant plasmid pkTH 1202 (DSM 2824) was digested with the restriction enzyme Hae III and the poly A tail was ligated to the 3 'ends of the fragments using a terminal transferase enzyme. The tail length was measured by H-A incorporation. The average length was about 70 A residues. Prior to use, the fastener 10 was denatured by boiling. Adenovirus-infected A-549 cells were used as a sample. Infected cells were incubated for 2 hours. Cells were harvested and disrupted with 1% sodium dodecyl sulfate solution. The solution contained about 106 cells / ml. The viscosity was reduced by sonication.
15 Kontrollina käytettiin ei-infektoituja A-549 soluja, joita käsiteltiin identtisesti. Ennen hybridisaatiota näytettä keitettiin 5 min. 0,02 M NaOH:ssa, jäähdytettiin 0°C:ksi ja neutraloitiin etikkahapolla.Uninfected A-549 cells treated identically were used as controls. Prior to hybridization, the sample was boiled for 5 min. In 0.02 M NaOH, cooled to 0 ° C and neutralized with acetic acid.
20 Testiä varten yhdistettiin koeputkessa 500.000 cpm detektori-koetinta, 50 ng kiinnitin-DNA:ta ja 10 /ui näytettä. Tilavuus säädettiin 50 /uliksi ja puskuriliuoksena käytettiin 0,6 M natriumkloridia 0,06 M natriumsitraattia, 0,02 M natriumfos-faattia (pH 7,6) ja 0,5 % natriumdodekyylisulfaattia. Seosta 25 inkuboitiin 1 tunti 65°C:n lämpötilassa.For the assay, 500,000 cpm of detector probe, 50 ng of fixative DNA, and 10 sample were combined in a test tube. The volume was adjusted to 50 and 0.6 M sodium chloride, 0.06 M sodium citrate, 0.02 M sodium phosphate (pH 7.6) and 0.5% sodium dodecyl sulfate were used as buffer solution. Mixture 25 was incubated for 1 hour at 65 ° C.
Hybridisaation jälkeen liuos jäähdytettiin + 20°C:ksi ja valutettiin hitaasti läpi kromatografiapatsaan, jossa oli 1 ml oligo dT-selluloosaa. Läpimennyt liuos otettiin talteen 30 ja valutettiin uudestaan patsaan läpi. Sen jälkeen patsasta pestiin 20 ml:lla liuosta, joka sisälsi 0,15 M natriumklori-dia, 0,015 M natriumfosfaattia (pH 7,6) ja 0,5 % natriumdodekyylisulfaattia. Kiinnittynyt DNA irroitettiin lopulta 1 ml:lla 0,02 M NaOHilla. Tämä liuos otettiin talteen ja sen 35 radioaktiivisuus määritettiin.After hybridization, the solution was cooled to + 20 ° C and slowly drained through a chromatography column containing 1 ml of oligo dT cellulose. The permeate was collected and drained again through the column. The column was then washed with 20 ml of a solution containing 0.15 M sodium chloride, 0.015 M sodium phosphate (pH 7.6) and 0.5% sodium dodecyl sulfate. The attached DNA was finally cleaved with 1 ml of 0.02 M NaOH. This solution was recovered and its radioactivity determined.
125 721 46 6125 721 46 6
Tulos: I-aktiivisuus (cpm) 05 Näyte: infektoidut solut Kontrollisolut 5230 325 10Result: I activity (cpm) 05 Sample: infected cells Control cells 5230 325 10
Esimerkki 2Example 2
Chlamydia trachomatiksen DNA:n tunnistaminen käyttäen 15 bioti ini-streptavidi inia 125Identification of Chlamydia trachomatis DNA using 15 bioti ini-streptavidin inia 125
Detektorikoettimena käytettiin I:lla leimattua rekom-binanttifaagia mkTH 1245, joka sisältää kaksi BamHI - Sali DNA fragmenttia kloonista pkTH 1220, jotka yhdessä ovat 20 kytkettynä Ml3mp8 vektoriin. Klooni pkTH 1220 on deponoitu kantakokoelmaan Deutsche Sammlung von Mikroorganismen numerolla DSM 2825 ja on kuvattu julkaisussa Palva et ai., FEMS Microbiology Letters 23, 83-89, 1984.I-labeled recombinant phage mkTH 1245 containing two BamHI-SalI DNA fragments from clone pkTH 1220, together linked to the M13mp8 vector, was used as a detector probe. Clone pkTH 1220 has been deposited in the strain collection Deutsche Sammlung von Microorganism under number DSM 2825 and is described in Palva et al., FEMS Microbiology Letters 23, 83-89, 1984.
25 Kiinnitinkoettimena käytettiin rekombinanttiplasmidia pkTHThe recombinant plasmid pkTH was used as a probe
1250. Tämä plasmidi koostuu 2,9 kb:n Sali - Clal fragmentista plasmidista pkTH 1220 (DSM 2825) sekä vektorista pAT 153. pkTH 1250 DNA:han liitettiin biotiinimolekyylejä kovalentti-sesti käyttäen tunnettua "nick-translaatio" -menetelmää 30 (Rigby et ai., J. Mol. Biol. 113, 237-251, 1977) ja biotine- ll-UTP:ta substraattina (Bethesda Research Laboratories, BRL). Kiinnitin-DNA keitettiin puskurissa 10 mM Tris-Cl pH 7,6, 1 mM EDTA 5 min ennen käyttöä.1250. This plasmid consists of a 2.9 kb SalI-ClaI fragment from plasmid pkTH 1220 (DSM 2825) and vector pAT 153. Biotin molecules were covalently ligated to pkTH 1250 DNA using a known "nick translation" method 30 (Rigby et al. et al., J. Mol. Biol. 113, 237-251, 1977) and biotin-11-UTP as a substrate (Bethesda Research Laboratories, BRL). Fastener DNA was boiled in 10 mM Tris-Cl pH 7.6, 1 mM EDTA for 5 min before use.
35 Näytteenä oli rekombinanttiplasmidi pkTH 1220 (DSM 2825).The sample was the recombinant plasmid pkTH 1220 (DSM 2825).
7 72146 Tämä plasmidi sisältää noin 10 kb Chlamydia trachomatikselle tunnusomaista DNA:ta kytkettynä vektoriin pBR322. Plasmidi toimii malli-DNA:na edustaen bakteerin genomi-DNA:ta. Ennen käyttöä plasmidia keitettiin 5 min 0,02 M NaOH:ssa, jonka 05 jälkeen liuosta neutraloitiin etikkahapolla.7 72146 This plasmid contains approximately 10 kb of Chlamydia trachomatis-specific DNA ligated into the vector pBR322. The plasmid acts as model DNA, representing the genomic DNA of the bacterium. Prior to use, the plasmid was boiled for 5 min in 0.02 M NaOH, after which the solution was neutralized with acetic acid.
Affiniteettimateriaalina käytetty Streptavidiini kytkettiin CNBr-aktivoituun Sepharoseert®^(Axen et ai., Nature 214, 1302-1304, 1967).Streptavidin used as an affinity material was coupled to CNBr-activated Sepharoseert® (Axen et al., Nature 214, 1302-1304, 1967).
1010
Testiä varten yhdistettiin koeputkessa 500.000 cpm koetinta, 50 ng kiinnitin DNA:ta ja 10 ng näyte DNA:ta. Tilavuus asetettiin 20 jul:ksi ja puskuriliuos oli sama kuin esimerkissä 1. Kontrolli-DNA oli vasikan kateenkorvan DNA.For the assay, 500,000 cpm of probe, 50 ng of fixative DNA, and 10 ng of sample DNA were combined in a test tube. The volume was set at 20 and the buffer solution was the same as in Example 1. The control DNA was calf thymus DNA.
1515
Seosta inkuboitiin 60 min 65°C:n lämpötilassa. Tämän jälkeen lisättiin 500 yul puskuriliuosta, jonka koostumus oli: 0,1 M Tris-Cl pH 7,5, 0,1 M NaCl, 2 mM MgClj, 0,05 % Triton x-100. Liuos fraktioitiin lopulta Streptavidiini-Sepharos^^-pylvääs-20 sä, siten että biotinyloitu DNA tarttui Streptavidiiniin, mutta muu DNA meni patsaan läpi. Radioaktiivinen koetin tarttui vain hybridimuodostuksen seurauksena. Tarttunut radioaktiivisuus määritettiin siirtämällä pylväs kokonaisuudessaan gammalaskijän laskentaputkeen.The mixture was incubated for 60 min at 65 ° C. Then, 500 μl of a buffer solution consisting of: 0.1 M Tris-Cl pH 7.5, 0.1 M NaCl, 2 mM MgCl 2, 0.05% Triton x-100 was added. The solution was finally fractionated on a Streptavidin-Sepharos column so that the biotinylated DNA adhered to the Streptavidin but other DNA passed through the column. The radioactive probe adhered only as a result of hybrid formation. Adherent radioactivity was determined by transferring the entire column to a gamma counter counting tube.
25 12525 125
Tulos: I-aktiivisuus (cpm) 30 Näyte: 10 ng pkTH 1220 10 ng kontrolli-DNA:ta 1350 115 8 721 46Result: I activity (cpm) 30 Sample: 10 ng pkTH 1220 10 ng control DNA 1350 115 8 721 46
Esimerkki 3Example 3
Plasmidin pBR322 DNA;n identifioiminen käyttäen antigeeni-vasta-aineparia, 05Identification of plasmid pBR322 DNA using antigen-antibody pair, 05
Detektorikoettimena käytettiin plasmidin pBR322 johdannaista, josta Pstl-Sall-fragmentti (3613-3651) on poistettu. Plasmidi leimattiin fotobiotiinilla käyttäen tunnettua menetelmää (Forster et ai., Nucleic Acids Res. 13, 745-761, 1985) ja 10 kaupallisia reagensseja.A derivative of plasmid pBR322 from which the PstI-SalI fragment (3613-3651) has been removed was used as a detector probe. The plasmid was labeled with photobiotin using a known method (Forster et al., Nucleic Acids Res. 13, 745-761, 1985) and 10 commercial reagents.
Kiinnitinkoettimena käytettiin rekombinanttifaagin M13mpll DNArta, johon plasmidin pBR322 Pstl-Sall-fragmentti oli liitetty. DNA oli sulfonoitu tunnettua menetelmää käyttäen 15 (Orgenics Ltd. Yavne, Israel).Recombinant phage M13mp111 DNA to which the PstI-SalI fragment of plasmid pBR322 was ligated was used as a probe probe. DNA was sulfonated using a known method (Orgenics Ltd. Yavne, Israel).
Näytteenä oli E. Coli HB101, johon oli liitetty plasmidi pBR322. Plasmidin pBR322 määrää lisättiin käyttäen kloramfenikoliamplifikaatiota (Maniatis et ai. Molecular 20 Cloning, A laboratory manual, Cold Spring Harbor Laboratory 1982). Bakteerisolut rikottiin lysotsyymillä ja niitä keitettiin NaOHsssa kuten julkaisussa Palva, J.Clin. Microbiol. 1J3, 92-100, 1983 on kuvattu.The sample was E. Coli HB101 to which plasmid pBR322 had been ligated. The amount of plasmid pBR322 was increased using chloramphenicol amplification (Maniatis et al. Molecular Cloning, A laboratory manual, Cold Spring Harbor Laboratory 1982). Bacterial cells were disrupted with lysozyme and boiled in NaOH as described in Palva, J. Clin. Microbiol. 1J3, 92-100, 1983.
25 Monoklonaaliset antisulfonivasta-aineet kiinnitettiin polystyreenistä valmistettujen mikrotiitterilevyjen kuoppiin standardimenetelmin (McKearn, Hybridomas: A New Dimension in Biological Analyses, ed. Kennett et ai., Plenum Press, 1980).Monoclonal antibodies were attached to the wells of polystyrene microtiter plates by standard methods (McKearn, Hybridomas: A New Dimension in Biological Analyzes, ed. Kennett et al., Plenum Press, 1980).
30 Testiä varten 5x10^ rikottua E. coli solua (sekä ilman että liitettynä pBR322-plasmidiin), 100 ng kiinnitin-DNA:ta ja 100 ng detektori-DNA:ta yhdistettiin hybridisaatioliuokseksi, jonka tilavuus säädettiin 50yul:ksi. Hybridisaatio-olosuhteet olivat samat kuin esimerkissä 1 lukuunottamatta sitä, että 9 72146 lisättiin 5 % polyetyleeniglykolia (PEG 6000) ja natriumdode-kyylisulfaattipitoisuus oli 0,1 %.For the assay, 5x10 6 disrupted E. coli cells (both airless and ligated into pBR322), 100 ng of fixer DNA, and 100 ng of detector DNA were pooled into a hybridization solution adjusted in volume to 50. The hybridization conditions were the same as in Example 1 except that 5% polyethylene glycol (PEG 6000) was added and the sodium dodecyl sulfate content was 0.1%.
Hybridisaation jälkeen liuos laimennettiin 250 yul:ksi lisää-05 mällä 0,02 M natriumfostaattia (pH 7,6), jonka jälkeen liuos siirrettiin mikrotiitterilevyn kuoppaan, johon vasta-aine oli kiinnitetty. Tämän jälkeen inkuboitiin 2 tuntia 37°C:ssa. Mikrotiitterilevyn kuoppaa pestiin sen jälkeen 0,15 M natriumkloridi-, 0,02 M natriumfosfaatti-, 0,05 % triton-10 X-100-liuoksella.After hybridization, the solution was diluted to 250 with the addition of 0.02 M sodium phosphate (pH 7.6), after which the solution was transferred to a well of a microtiter plate to which the antibody was attached. It was then incubated for 2 hours at 37 ° C. The well of the microtiter plate was then washed with 0.15 M sodium chloride, 0.02 M sodium phosphate, 0.05% Triton-10 X-100 solution.
Detektorikoetin havaittiin lisäämällä streptavidiinia (BRL), pesemällä, lisäämällä biotinyloitua alkaalista fosfataasia (BRL) ja pesemällä kuten julkaisussa Leary et ai., Proc.The detector probe was detected by the addition of streptavidin (BRL), washing, addition of biotinylated alkaline phosphatase (BRL) and washing as described in Leary et al., Proc.
15 Natl. Acad. Sei. USA, 80, 4045-4049, 1983 on kuvattu. Lopuksi lisättiin 250 μΐ paranitrofenyylifosfaattiliuosta (35 mg/ml, Sigma) dietanoliamiinipuskurissa (pH 10). 60 minuutin kuluttua reaktio pysähdytettiin ja absorbanssi mitattiin 410 nm:ssa.15 Natl. Acad. Sci. USA, 80, 4045-4049, 1983. Finally, 250 μl of paranitrophenyl phosphate solution (35 mg / ml, Sigma) in diethanolamine buffer (pH 10) was added. After 60 minutes, the reaction was stopped and the absorbance was measured at 410 nm.
2020
Tulos: A 410 nm 25 Näyte: solut joihin oli Kontrollisolut liitetty pBR322 (ilman pBR322) > 2 0,1Result: Δ 410 nm 25 Sample: cells to which Control cells were attached pBR322 (without pBR322)> 2 0.1
Claims (7)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI850004A FI72146C (en) | 1985-01-02 | 1985-01-02 | Procedure for Identifying Nucleic Acids. |
| CH5378/85A CH666696A5 (en) | 1985-01-02 | 1985-12-17 | METHOD FOR IDENTIFYING NUCLEIC ACIDS. |
| GB08531414A GB2169403B (en) | 1985-01-02 | 1985-12-20 | Identification of nucleic acids |
| BE0/216059A BE903937A (en) | 1985-01-02 | 1985-12-24 | METHOD FOR THE IDENTIFICATION OF NUCLEIC ACIDS. |
| JP60299797A JPH0669400B2 (en) | 1985-01-02 | 1985-12-27 | Nucleic acid identification method |
| NO855308A NO166743C (en) | 1985-01-02 | 1985-12-27 | PROCEDURE FOR IDENTIFICATION OF NUCLEIC ACIDS. |
| HU855030A HU196453B (en) | 1985-01-02 | 1985-12-29 | Process for the identification of nucleinic acids |
| RO121637A RO94651B (en) | 1985-01-02 | 1985-12-30 | Method for identifying the nucleic acids |
| LU86238A LU86238A1 (en) | 1985-01-02 | 1985-12-30 | METHOD FOR THE IDENTIFICATION OF NUCLEIC ACIDS |
| IT23408/85A IT1201514B (en) | 1985-01-02 | 1985-12-30 | PROCEDURE FOR THE IDENTIFICATION OF NUCLEIC ACIDS |
| DE19853546312 DE3546312A1 (en) | 1985-01-02 | 1985-12-30 | METHOD FOR IDENTIFYING NUCLEIC ACIDS |
| AT0376785A AT397514B (en) | 1985-01-02 | 1985-12-30 | METHOD FOR IDENTIFYING NUCLEIC ACIDS |
| ZA859895A ZA859895B (en) | 1985-01-02 | 1985-12-30 | A method for the identification of nucleic acids |
| FR858519394A FR2575493B1 (en) | 1985-01-02 | 1985-12-30 | METHOD FOR THE IDENTIFICATION OF NUCLEIC ACIDS |
| CA000498834A CA1271705A (en) | 1985-01-02 | 1985-12-31 | Method for the identification of nucleic acids |
| IE333385A IE58290B1 (en) | 1985-01-02 | 1985-12-31 | A method for the identification of nucleic acids |
| AU51748/85A AU561382B2 (en) | 1985-01-02 | 1985-12-31 | Identification of nucleic acid by hybridization probes |
| NLAANVRAGE8503597,A NL189427C (en) | 1985-01-02 | 1985-12-31 | METHOD FOR IDENTIFYING NUCLEIC ACIDS. |
| IL77489A IL77489A (en) | 1985-01-02 | 1985-12-31 | Method for the identification of nucleic acids in solution by hybridisation with at least two probes one labelled,the other bonded to one component of a specific binding pair |
| SE8600011A SE463212B (en) | 1985-01-02 | 1986-01-02 | METHOD FOR IDENTIFYING NUCLEIC ACIDS |
| DK000386A DK164932C (en) | 1985-01-02 | 1986-01-02 | PROCEDURE FOR IDENTIFICATION OF NUCLEIC ACIDS BY A METHOD OF HYBRIDIZATION, WHICH AT LEAST TWO SUNS ARE IN THE SAME SOLUTION PHASE, SINCE THE ONE, THE DETECTOR SENSOR, IS MARKED WITH A DETECTABLE MARKET |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI850004 | 1985-01-02 | ||
| FI850004A FI72146C (en) | 1985-01-02 | 1985-01-02 | Procedure for Identifying Nucleic Acids. |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI850004A0 FI850004A0 (en) | 1985-01-02 |
| FI850004L FI850004L (en) | 1986-07-03 |
| FI72146B FI72146B (en) | 1986-12-31 |
| FI72146C true FI72146C (en) | 1987-04-13 |
Family
ID=8520136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI850004A FI72146C (en) | 1985-01-02 | 1985-01-02 | Procedure for Identifying Nucleic Acids. |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPH0669400B2 (en) |
| AT (1) | AT397514B (en) |
| AU (1) | AU561382B2 (en) |
| BE (1) | BE903937A (en) |
| CA (1) | CA1271705A (en) |
| CH (1) | CH666696A5 (en) |
| DE (1) | DE3546312A1 (en) |
| DK (1) | DK164932C (en) |
| FI (1) | FI72146C (en) |
| FR (1) | FR2575493B1 (en) |
| GB (1) | GB2169403B (en) |
| HU (1) | HU196453B (en) |
| IE (1) | IE58290B1 (en) |
| IL (1) | IL77489A (en) |
| IT (1) | IT1201514B (en) |
| LU (1) | LU86238A1 (en) |
| NL (1) | NL189427C (en) |
| NO (1) | NO166743C (en) |
| RO (1) | RO94651B (en) |
| SE (1) | SE463212B (en) |
| ZA (1) | ZA859895B (en) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5288609A (en) * | 1984-04-27 | 1994-02-22 | Enzo Diagnostics, Inc. | Capture sandwich hybridization method and composition |
| US6060237A (en) * | 1985-02-26 | 2000-05-09 | Biostar, Inc. | Devices and methods for optical detection of nucleic acid hybridization |
| IL79112A (en) * | 1985-06-13 | 1992-01-15 | Abbott Lab | Method for the isolation of a nucleic acid sequence and kit for performing a hybridization assay |
| US4868105A (en) * | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| US4910300A (en) * | 1985-12-11 | 1990-03-20 | Chiron Corporation | Method for making nucleic acid probes |
| US4882269A (en) * | 1985-12-13 | 1989-11-21 | Princeton University | Amplified hybridization assay |
| FI76119C (en) * | 1986-02-27 | 1988-09-09 | Orion Yhtymae Oy | QUANTITATIVE BEARING OF NUCLEIN SYRAMOLEKYLER AND REAGENTS FOERPACKNING SOM ANVAENDS VID FOERFARANDET. |
| AU622104B2 (en) * | 1987-03-11 | 1992-04-02 | Sangtec Molecular Diagnostics Ab | Method of assaying of nucleic acids, a reagent combination and kit therefore |
| FI894132L (en) * | 1987-06-26 | 1989-09-01 | Du Pont | AFFINITETSAVLAEGSNING AV KONTAMINERANDE SEKVENSER UR KLONAD HYBRIDNUCLEIINSYRA GENOM ATT ANVAENDA INFAONGANDE PAERLOR. |
| AU623090B2 (en) * | 1987-07-31 | 1992-05-07 | Gen-Probe Incorporated | Assay for polynucleotides employing oligonucleotides to eliminate undesirable cross reactions |
| EP0305145A3 (en) * | 1987-08-24 | 1990-05-02 | Ortho Diagnostic Systems Inc. | Methods and probes for detecting nucleic acids |
| EP0304845A3 (en) * | 1987-08-28 | 1991-03-06 | Profile Diagnostic Sciences Inc. | Method and kit for assaying gene expressions |
| CA1325761C (en) * | 1987-12-25 | 1994-01-04 | Takanori Oka | Method of detecting an intended nucleic acid in a sample |
| DE3800644A1 (en) * | 1988-01-12 | 1989-07-20 | Boehringer Mannheim Gmbh | PROCESS FOR HIGHLY SPECIFIC DETECTION OF NUCLEIC ACIDS IN SOLUTION |
| US5104791A (en) * | 1988-02-09 | 1992-04-14 | E. I. Du Pont De Nemours And Company | Particle counting nucleic acid hybridization assays |
| DE68919706T2 (en) * | 1988-05-10 | 1995-04-13 | Du Pont | METHOD FOR QUICK DETECTING NUCLEIC ACIDS. |
| US5185243A (en) * | 1988-08-25 | 1993-02-09 | Syntex (U.S.A.) Inc. | Method for detection of specific nucleic acid sequences |
| AU629845B2 (en) * | 1988-08-30 | 1992-10-15 | Abbott Laboratories | Detection and amplification of target nucleic acid sequences |
| US5858652A (en) * | 1988-08-30 | 1999-01-12 | Abbott Laboratories | Detection and amplification of target nucleic acid sequences |
| GB2225112A (en) * | 1988-11-22 | 1990-05-23 | Ici Plc | Hybridisation probes |
| US5082935A (en) * | 1988-12-15 | 1992-01-21 | Amoco Corporation | Diagnostic reagents made by attaching cytidine containing nucleic acid probes to amino functionalized solid supports by bisulfite mediated transamination |
| AU5188190A (en) * | 1989-02-06 | 1990-08-24 | Gene-Trak Systems | Probes and methods for the detection of listeria |
| CA2049043A1 (en) | 1989-03-10 | 1990-09-11 | Mark L. Collins | Immobilized oligo-nucleotide probes and uses therefor |
| AU5347690A (en) * | 1989-03-10 | 1990-10-09 | Gene-Trak Systems | Preventing interference with affinity capture schemes |
| US5334501A (en) * | 1989-07-11 | 1994-08-02 | Microprobe Corporation | Quantification of bacteria using a nucleic acid hybridization assay |
| JPH05501052A (en) * | 1989-07-11 | 1993-03-04 | マイクロプローブ・コーポレーション | Quantification of bacteria using a nucleic acid hybridization assay |
| GB8924989D0 (en) * | 1989-11-06 | 1989-12-28 | Scotgen Ltd | Method and device for the detection of antibiotic resistance |
| US5580970A (en) * | 1989-12-01 | 1996-12-03 | Amoco Corporation | Detection of HPV transcripts |
| AU7429591A (en) * | 1990-04-18 | 1991-10-24 | Gene-Trak Systems | Nucleic acid probes for the detection of giardia lamblia |
| EP0529070A1 (en) * | 1991-02-27 | 1993-03-03 | Amoco Corporation | Methods for improving the sensitivity of hybridization assays |
| WO1993020234A1 (en) * | 1992-03-31 | 1993-10-14 | E.I. Du Pont De Nemours And Company | A rapid, high capacity nucleic acid based assay |
| US7713528B1 (en) | 1993-02-18 | 2010-05-11 | Enzo Therapeutics, Inc. | Method for in vivo delivery of active compounds using reagent conjugate |
| RU2146707C1 (en) * | 1996-04-11 | 2000-03-20 | Куликова Валентина Филипповна | Method of detection of analyzed sequence of nucleic acid |
| US5853993A (en) * | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
| GB0016833D0 (en) | 2000-07-07 | 2000-08-30 | Lee Helen | Improved dipstick assays (2) |
| US7465540B2 (en) | 2000-09-21 | 2008-12-16 | Luminex Corporation | Multiple reporter read-out for bioassays |
| CN1303221C (en) * | 2003-01-27 | 2007-03-07 | 英科新创(厦门)科技有限公司 | Method for detecting target nucleic acid using affinity amplifying integrated signal group |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI63596C (en) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
| FR2518755B1 (en) * | 1981-12-23 | 1986-04-11 | Pasteur Institut | PROBE CONTAINING MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND USE OF THE SAME TO DETECT AND CHARACTERIZE A HOMOLOGATED DNA SEQUENCE |
| GB8306426D0 (en) * | 1983-03-09 | 1983-04-13 | Malcolm A D B | Detecting polynucleotide sequence |
| CA1228811A (en) * | 1983-05-05 | 1987-11-03 | Robert G. Pergolizzi | Assay method utilizing polynucleotide sequences |
| NO843838L (en) * | 1983-09-26 | 1985-03-27 | Ortho Diagnostic Systems Inc | PROCEDURE FOR DETECTING NUCLEIC ACID |
| ZA849594B (en) * | 1983-12-12 | 1985-08-28 | Miles Lab | Nucleic acid hybridization assay employing antibodies to intercalation complexes |
| FR2558172B1 (en) * | 1984-01-16 | 1986-06-13 | Inst Nat Sante Rech Med | PROBE CONTAINING MODIFIED NUCLEIC ACID AND RECOGNITION BY SPECIFIC ANTIBODIES AND USE OF SUCH PROBE AND THESE SPECIFIC ANTIBODIES TO DETECT AND CHARACTERIZE A HOMOLOGATED DNA SEQUENCE |
| CA1223222A (en) * | 1984-02-22 | 1987-06-23 | Nanibhushan Dattagupta | Immobilized nucleic acid-containing probes |
| FR2560298B1 (en) * | 1984-02-28 | 1988-07-15 | Mors | METHOD AND DEVICE FOR ADJUSTING THE PRECISION OF THE PRESSURE DROP OF A FLUID INITIALLY AT HIGH PRESSURE, SUCH AS A HYDRAULIC FLUID FOR EXAMPLE SUPPLYING A HYDRAULIC GROUP, AND APPLICATION OF THE METHOD TO THE DEVICE IN A HYDRAULIC GROUP OR PLANT INTEGRATED OR NOT, ESPECIALLY IN A MACHINE TABLE OR ANY TOOL SUPPORT DEVICE |
| NZ211453A (en) * | 1984-03-22 | 1989-01-06 | Biotechnology Research Enterpr | Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides |
| US4766062A (en) * | 1984-05-07 | 1988-08-23 | Allied Corporation | Displacement polynucleotide assay method and polynucleotide complex reagent therefor |
-
1985
- 1985-01-02 FI FI850004A patent/FI72146C/en not_active IP Right Cessation
- 1985-12-17 CH CH5378/85A patent/CH666696A5/en not_active IP Right Cessation
- 1985-12-20 GB GB08531414A patent/GB2169403B/en not_active Expired
- 1985-12-24 BE BE0/216059A patent/BE903937A/en not_active IP Right Cessation
- 1985-12-27 JP JP60299797A patent/JPH0669400B2/en not_active Expired - Lifetime
- 1985-12-27 NO NO855308A patent/NO166743C/en not_active IP Right Cessation
- 1985-12-29 HU HU855030A patent/HU196453B/en unknown
- 1985-12-30 RO RO121637A patent/RO94651B/en unknown
- 1985-12-30 ZA ZA859895A patent/ZA859895B/en unknown
- 1985-12-30 IT IT23408/85A patent/IT1201514B/en active
- 1985-12-30 LU LU86238A patent/LU86238A1/en unknown
- 1985-12-30 FR FR858519394A patent/FR2575493B1/en not_active Expired - Lifetime
- 1985-12-30 DE DE19853546312 patent/DE3546312A1/en active Granted
- 1985-12-30 AT AT0376785A patent/AT397514B/en not_active IP Right Cessation
- 1985-12-31 NL NLAANVRAGE8503597,A patent/NL189427C/en not_active IP Right Cessation
- 1985-12-31 IE IE333385A patent/IE58290B1/en not_active IP Right Cessation
- 1985-12-31 CA CA000498834A patent/CA1271705A/en not_active Expired - Lifetime
- 1985-12-31 IL IL77489A patent/IL77489A/en not_active IP Right Cessation
- 1985-12-31 AU AU51748/85A patent/AU561382B2/en not_active Expired
-
1986
- 1986-01-02 SE SE8600011A patent/SE463212B/en not_active IP Right Cessation
- 1986-01-02 DK DK000386A patent/DK164932C/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI72146C (en) | Procedure for Identifying Nucleic Acids. | |
| US4563417A (en) | Nucleic acid hybridization assay employing antibodies to intercalation complexes | |
| US4562159A (en) | Diagnostic test for hepatitis B virus | |
| AU597896B2 (en) | Method and kit for performing nucleic acid hybridization assays | |
| CA1253777A (en) | Nucleic acid hybridization assay employing immobilized rna probes | |
| US6555317B2 (en) | Detection of differences in nucleic acids | |
| US5981171A (en) | Diagnostic assays using nucleic acid probes | |
| JPH0740960B2 (en) | Nucleic acid detection kit | |
| EP0146815B1 (en) | Nucleic acid hybridization assay employing antibodies to intercalation complexes | |
| US4840892A (en) | Polynucleotide hybridization probes | |
| Stark et al. | Immunomagnetic separation and solid-phase detection of Bordetella pertussis | |
| EP0172153B1 (en) | Polynucleotide hybridization probes | |
| EP0253894A1 (en) | Dna probe and method of preparing the same | |
| WO2000043545A2 (en) | Detection of drug resistant organisms | |
| JPH0531108B2 (en) | ||
| EP0401313B1 (en) | Macromolecular conjugate | |
| WO2000043546A9 (en) | Detection of drug resistant organisms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: SANGTEC MEDICAL AB |
|
| FG | Patent granted |
Owner name: SANGTEC MOLECULAR DIAGNOSTICS AB |
|
| MA | Patent expired |